No. of studies |
21b
|
No. of patients |
643 |
Study type, n |
|
Retrospective case series |
11 |
Prospective case series |
6 |
Randomized controlled trials |
2 |
Prospective comparative studies |
1 |
Retrospective comparative studies |
1 |
Follow-up duration,c mo |
25-151 |
Defects (n = 589), n (%) |
|
Primary |
498 (85) |
Secondary |
91 (15) |
Berndt and Harty classification (n = 156), n (%) |
|
Stage I |
6 (4) |
Stage II |
26 (17) |
Stage III |
30 (19) |
Stage IV |
28 (18) |
Stage V |
66 (42) |
RTS rate (n = 300),c mean (95% CI), % |
22-100 (6-100) |
RTS rate to preinjury level (n = 300),c mean (95% CI), % |
21-100 (8-100) |
Time to RTS (n = 133),c wk |
13-26 |